Please login to the form below

Not currently logged in
Email:
Password:

guselkumab

This page shows the latest guselkumab news and features for those working in and with pharma, biotech and healthcare.

MorphoSys expands oncology pipeline with $1.7bn acquisition of Constellation Pharmaceuticals

MorphoSys expands oncology pipeline with $1.7bn acquisition of Constellation Pharmaceuticals

In return, Royalty Pharma will gain the rights to receive 100% of MorphoSys’ royalties on net sales of its commercial drug Tremfya (guselkumab), as well as 80% of future royalties and

Latest news

More from news
Approximately 2 fully matching, plus 36 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...